PHT Corporation Scientists Present New Research on Patient Technology Preferences in COPD and Diabetes Clinical Research at Key Industry Events

Scientific experts from the leader in patient-centric apps for improved clinical outcomes present patient preference data for electronic data collection

BOSTON & GENEVA--()--Join PHT Corporation scientists as they advance the adoption of electronic clinical outcome assessment (eCOA) Systems for improved patient-focused research. The PHT Clinical Science team is dedicated to sharing scientific insights and best practices from implementing eCOA Systems in over 750 clinical trials resulting in 21+ regulatory approvals to advance the adoption of eClinical technologies that speed the development of new drugs to improve quality of life.

The PHT Science presentations this spring are a continuation of preference data results being released by PHT on new research from a sub-study within a SF-36v2 Equivalency Mode Study about the common usage practices, patterns and preferences of Diabetes and COPD patients to gather, provide and interact with technology and use it to manage their disease.

The data will be presented by PHT Science team leader, Valdo Arnera MD, General Manager of PHT Europe and Donna Reed, Key Account Manager. They will discuss the results of this research by lead research author Laura Khurana MPH, PHT Scientific Advisor and its impact on usage and design of eCOA Systems for clinical research and in clinical care.

Join them for these presentations:

Advanced Technologies & Treatments for Diabetes Conference, Paris, France, 18-21 February – “Diabetes Patient Preferences for Using Technology to Communicate with Physicians”. Meet us there: http://bit.ly/1M6BvJE

International Workshop on Lung Health, Valencia, Spain, 19-21 February – “Engaging Patients with eClinical Technology: Incorporating Patient Preferences into COPD Care and Clinical Trials”. Meet us there: http://bit.ly/1zPlVeX

Diabetes UK Professional Conference , London UK, 11-13 March – “Patient Preferences for Using Technology to Track and Self-Manage Diabetes”. Meet us there: http://bit.ly/1DY96zo

Also in March, join Valdo Arnera MD and leading Pharma at the MCT Congress in Edinburgh, UK as they discuss: “What are the Real Barriers to Big Pharma Adopting New Technologies”? Meet us there: http://bit.ly/1IG3jVS

About PHT Corporation

PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedInFacebookTwitterGoogle+ and YouTube.

Contacts

for PHT
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com

Release Summary

Patient-driven eData systems innovator PHT Corp presents results on new research from sub-study in SF-36v2 Equivalency Mode Study on practices, patterns and preferences of Diabetes and COPD patients

Contacts

for PHT
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com